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Abstract 
Aims: The aim of the study was to explore the relative efficiency and effectiveness 
of targeted versus universal screening for at-risk alcohol use in a primary care 
population in the United Kingdom. 
Methods: The study was a randomised evaluation of screening approach (targeted 
versus universal) for consecutive attendees at primary care aged 18 years or more. 
Targeted screening involved screening any patient attending with one of the targeted 
presentations, conditions associated with excessive alcohol consumption: mental 
health, gastro-intestinal, hypertension, minor injuries or a new patient registration. In 
the universal arm of the study all presentations in the recruitment period were 
included. Universal sceening included all patients presenting to allocated practices. 
Results: A total of 3562 potential participants were approached. The odds ratio of 
being screen positive was higher for the targeted group versus the universal group. 
Yet the vast majority of those screening positive in the universal group of the study 
would have been missed by a targeted approach. A combination of age and gender 
was a more efficient approach than targeting by clinical condition or context.   
Conclusions: While screening targeted by age and gender is more efficient than 
universal screening, targeting by clinical condition or presentation is not. Further 
universal screening is more effective in identifying the full range of patients who 
could benefit from brief alcohol interventions, and would therefore have greater 
public health impact. 
 
Background 
Reducing alcohol-related morbidity and mortality is a key priority for health services 
worldwide. Internationally alcohol consumption accounts for 3.8% of all avoidable 
deaths and 4.6% of disability adjusted life years (DALY). This figure is higher in 
developed countries such as the UK, where alcohol is the third largest risk factor, 
accounting for 9.2% of DALY’s (Global Burden of Disease Study, 2015). In the UK, it 
is estimated that 24% of of the adult population, aged 16 or more, are at-risk drinkers 
(33% of men and 16% of women)(HSCIC, 2009). Yet 98% of these are not identified 
at the time of presentation in primary care (Anderson et al., 2016) (Brown et al., 
2016) (Cheeta et al., 2008) (Kaner et al., 1999). This is despite the fact that 90% of 
patient contact with the health service occurs in the primary care setting.   
There is considerable evidence of the benefits of screening and brief intervention for 
at-risk alcohol users in primary care, aimed at reducing consumption and 
subsequent alcohol-related harm (Moyer et al., 2002) (Bertholet et al., 2005; Kaner 
et al., 2007a; Whitlock et al., 2002). There is also evidence that paper based 
screening tests, such as the Alcohol Use Disorders Identification Test (AUDIT; 
(Saunders et al., 1993)), are more effective than biochemical markers of excessive 
alcohol use (Coulton et al., 2006). In addition, shorter screening tools such as the 
Fast Alcohol Screening Test (FAST; (Hodgson et al., 2002)) and Single Alcohol 
Screening Question (SASQ; (Canagasaby and Vinson, 2005)) also demonstrate 
excellent diagnostic properties when compared with AUDIT. Despite this, screening 
is rarely conducted in practice (Brown et al., 2016) (Kaner, 2010), and the efficiency 
and acceptability of screening for alcohol use in primary care has been questioned 
(Beich et al., 2002; Beich et al., 2003). 
Where screening does take place concern has been expressed regarding the 
relative value of screening all attendees in primary care, universal screening, as 
opposed to those attending with a higher likelihood of alcohol-related problems, 
targeted screening (Prime Minister's Strategy Unit, 2004). Yet targeted as opposed 
to universal screening approaches have not been formally evaluated in terms of their 
efficiency or effectiveness. Moreover, while a number of key health conditions are 
known to be associated with excessive alcohol consumption based on attributable 
risk fractions (Anderson and Baumberg, 2006; Rehm et al., 2009), these conditions 
are far less prevalent in primary care settings than inpatient settings. In addition, 
while the prevalence of excessive alcohol use is known to vary by age and gender, 
the potential of these demographic indicators as targets for screening activity has not 
been formally evaluated. 
In order to address these gaps in the evidence, we evaluated targeted versus 
universal screening approaches as part of a large multi-centre cluster randomised 
controlled trial of screening and brief interventions in primary care in the United 
Kingdom, the SIPS Primary Healthcare trial (SIPS-PHC) (Kaner et al., 2013a; Kaner 
et al., 2009). 
Methods/Design 
The reported study was planned as one element of a cluster randomized trial of 
opportunistic screening and brief interventions for alcohol use in primary care 
settings in the United Kingdom (Kaner et al., 2009). The results of the brief 
intervention aspect of the trial are reported elsewhere (Kaner et al., 2013b). 
 
Initially, a questionnaire survey was undertaken to ascertain suitable targets for 
screening in primary care. Doctors and nurses in participating practices were invited 
to take part in the survey. The survey aimed to ascertain practitioner preferences 
regarding appropriate clinical targets for alcohol screening. Based on a review of the 
literature participants were asked whether they considered key clinical conditions or 
key contexts as the appropriate target for screening. Additionally, practitioners were 
asked on a scale from 1 to 5, where 1 indicated ‘extremely important’ and 5 ‘not at all 
important’, the relative importance of a number of key conditions and key contexts. 
Respondents were provided with an opportunity to add any key conditions or 
contexts they felt had not been identified by the literature review. 
 
The evaluation of screening approach incorporated cluster randomisation of 
practices, to avoid the risk of bias through contamination. Practices were allocated at 
random to either targeted or universal screening, and screening using one of two 
screening tools, FAST (Hodgson et al., 2002) or the SASQ (Canagasaby and 
Vinson, 2005). Random allocation was stratified by geographical area, North versus 
South, ensuring a similar number of practices in each geographical area. Each 
screening approach, targeted or universal, employed both of the screening tools. 
The outcome was scoring positive for at-risk alcohol consumption on the allocated 
screening tool.  
 
Settings 
Twenty-nine general practices across London, South East  and North East England 
participated in the study between May 2008 and July 2009. All participating practices 
delivered a full range of medical services across a range of urban and rural, socially 
deprived and affluent communities. At the time of the study none of the participating 
practices routinely screened patients for alcohol use. 
 
Randomisation 
Randomisation was conducted independent of the research team, after practices 
had been recruited and consented to participate. An additional five stand-by 
practices were later randomly allocated due to insufficient recruitment in the initial 
practices.  
 
Inclusion and exclusion criteria 
We included patients who were: alert and orientated, aged 18 or over, resident within 
20 miles of the practice, and able to understand English sufficiently to complete 
study questionnaires. In the targeted group only those who presented with one of the 
targeted conditions were included. We excluded patients already involved in an 
alcohol research study or who were specifically seeking help for alcohol problems. 
Patients who were severely injured or unwell, grossly intoxicated or who had no fixed 
abode were also excluded.   
 
Consent 
Primary care staff initially established verbal consent to check eligibility for the study. 
At this stage, they collected basic demographic information and screened the 
patient, recording the presenting condition. Full ethical approval was provided by the 
NHS MREC (06/MREC02/90) and governance approval was granted by all 
participating Primary Care Trusts. 
 
Outcome tools 
 FAST (Hodgson et al., 2002) is a four item alcohol screening test derived from the 
AUDIT (Saunders et al., 1993). It is designed for use in a busy clinical settings, as 
the majority of respondents are identified as positive on the first question. This asks 
about the frequency of heavy episodic alcohol use in a similar manner to item 3 of 
AUDIT. If a respondent answers monthly or less the remaining three questions are 
assessed, corresponding to items 8, 9 and 10 of the AUDIT. A score of 3 or more is 
considered positive for at-risk alcohol consumption. 
 
SASQ (Canagasaby and Vinson, 2005) was validated in the United States and is 
similar to question 1 of FAST and item 3 of AUDIT. A response of ‘daily or almost 
daily’, ‘weekly’ or ‘monthly’ is a positive screen. We modified the original SASQ to 
reflect UK definitions of heavy episodic alcohol use; 8 or more standard drinks for 
men and 6 for women in a single drinking episode. A standard drink contains 8g of 
ethanol. We use the acronym M-SASQ to reflect this modification. 
 
Analysis 
We compiled and analysed the results of the study using STATA v14.  
 
Initially we calculated the mean ranking of key conditions and contexts in the practice 
staff survey. The five highest ranked conditions or contexts were selected as the 
main targets in the targeted group of the study.  
 
We used logistic regression to estimate the odds ratio of positive screens in the 
universal and targeted groups of the study. We incorporated screening instrument 
into the analysis to explore for any potential interaction between screening tool and 
screening approach. As the study was clustered, with patients nested within 
practices, we adjusted our analysis using the Huber-White Sandwich Estimator to 
provide robust standard errors associated with our odds ratio and 95% confidence 
intervals. 
 
In order to explore the efficiency of targeted screening, we established whether 
participants in the universal group had presented with one of the conditions or 
contexts associated with the targeted group. Two independent clinical experts 
assessed and categorised the reason for presentation, independently resolving any 
divergence through consensus.  
 
To assess the potential role of age and gender as targets for screening we 
conducted an exploratory analysis using patients in the universal arm of the study.   
 
Results 
Responses were received from 90 (83%) of those clinical staff surveyed. At least one 
response was received from each of the participating practices. The majority of 
respondents expressed a preference for targeted rather than universal screening 
(67.8% vs 14.4%), and targeting using key conditions rather than contexts (54.4% vs 
24.4%). In terms of key conditions, the highest mean rating was for gastrointestinal 
and mental health conditions, with hypertension and minor injuries considered 
moderately important. In terms of key contexts new patient registrations were rated 
higher than any other. Ratings for key conditions and contexts are presented in 
Table 1. When asked if any other conditions or contexts were considered important, 
respondents replied with a varied selection including blood tests, obesity, medical 
certificates and exercise referrals. 
 
The targeted group of the study approached all participants who attended with any 
one of the five most important conditions or contexts: mental health problems, 
gastrointestinal problems, hypertension, minor injuries and new patient registrations. 
 
Overall 3562 potential participants were approached and 3021 (85%) were deemed 
to be eligible and consented to be screened. Of whom, 908 (30%) scored positive for 
at-risk alcohol consumption using one of the screening tools. Those in the targeted 
group were slightly younger (48.8 vs 51.8 years), more likely to be male (56.3% vs 
41.5%) and more likely to smoke (26.7% vs 22.7%) compared with the universal 
group (Table 2). 
 
The prevalence of at-risk alcohol consumption was significantly higher in the 
targeted group (36.2%) than the universal group (25.6%). The odds ratio of at-risk 
consumption was significantly higher for the targeted group versus the universal 
group (1.65; 95% CI 1.41 to 1.93) (table 3). This was not influenced by the tool used 
for screening.  
 
In the targeted group, the most commonly used targets for screening were 
hypertension (633; 49.5%) and new patient registrations (275; 21.5%) (Table 3). Out 
of the five targets, four had significantly higher odds ratio of a positive screen than 
universal screening; mental health conditions, gastrointestinal problems, 
hypertension and minor injuries.   
 When we selected out of the universal group those presentations which would have 
fallen into one of the targeted conditions, no targeted condition is significantly 
associated with screening positive for at-risk drinking. In the universal group of the 
study the most common presentations were hypertension (142; 8.2%) and mental 
health conditions (95; 5.4%). Overall, 1388 (79.7%) of participants did not fall into 
any of the targeted screening conditions or contexts. This accounted for 81% of 
those who screened positive for at-risk alcohol consumption in the universal group. 
 
The impact of age and gender as predictors of excessive alcohol consumption were 
explored using the universal arm of the study alone. The youngest age-group, 18 – 
24 years had the highest prevalence of at-risk alcohol consumption and the oldest, 
65 years or more, the lowest (41.1% vs 12.8%). Yet at the same time, they 
represented the smallest proportion of attendees (8.8%). The 18-24 year age group 
had a significantly higher odds ratio compared with the rest of the population of 
screening positive (2.18; 95% CI 1.55 to 3.08). More marked differences were 
apparent when gender was taken into consideration with males significantly more 
likely to screen positive than females (2.54; 95% CI 2.04 to 3.16), and this was 
particularly apparent in the 18-24 (3.95; 95% CI 2.38 to 6.56), 45-54 (1.83; 95% CI 
1.19 to 2.81) and 55-64 (2.38; 95% CI 1.29 to 4.41) age groups. Screening all 
attendees aged 18 to 34 years, and all older age males would involve screening 57% 
of attendees. This would yield 78% of all positive screens, a more efficient approach 
than targeting by clinical condition or context, but this approach still missed 22% of 
screen positives. 
 
Discussion 
The study aimed to address two important questions regarding screening (or case 
identification) for at-risk alcohol consumption in primary care settings. The first 
concerned the efficiency and effectiveness of targeted as opposed to universal 
screening. The design of the study was pragmatic and targets for screening were 
selected by experts from the existing literature. Then those involved in the actual 
screening used their own clinical judgement and experience to derive the five most 
important conditions, or contexts for screening. The results indicate that in terms of 
efficiency, targeted screening overall yields a higher prevalence of at-risk alcohol 
users than universal screening, and the probability of consuming alcohol at at-risk 
levels in the targeted group was significantly higher than the universal group.  
 
Yet in terms of effectiveness, targeted screening is less effective at identifying those 
who may benefit from intervention, as 81% of those who screened positive in the 
universal group would have been missed by applying the targeted criteria. When we 
consider that the effectiveness of screening and brief interventions for alcohol use in 
primary care, in terms of the numbers needed to treat (NNT), is of the order of 7 – 9 
(Fleming et al., 2002; Kaner et al., 2007b; Ockene et al., 1999) and that this 
compares favourably with the NNT for other medical conditions managed in primary 
care such as, the use of statins to prevent cardiovascular mortality (NNT 30 – 90) 
(SIGN, 2000), and interventions for smoking cessation (NNT 20) (Stead et al., 2008). 
Universal screening is likely to be the more effective screening approach in primary 
care and should mirror the universal screening for smoking every 27 months in the 
Quality and Outcomes Framework for General Practice (NHS, 2012).  
 
The second question addresses whether other demographic factors, age and 
gender, may be more appropriate targets for screening activity than clinical 
presentations. The results tend to suggest that those attendees aged 18-35 years 
and males aged over 35 are significantly more likely to be at-risk alcohol users. 
Targeting by age and gender is more efficient than targeting by clinical condition or 
context, but this still misses almost a quarter of those who may benefit from 
intervention.  
 
The strengths of the study are that it was a large-scale cluster randomised 
evaluation that embedded screening into ordinary clinical practice. The study used 
established, valid and reliable screening tools. Rates of eligibility and consent to be 
screened were higher than in most similar studies and the sample is similar to the 
population routinely attending primary care in the UK.    
 
Limitations in the study can be considered from two perspectives. We used a small 
number of targeted conditions and contexts, to maximise the acceptability of targeted 
screening. This may have excluded some appropriate targets. Yet we based this on 
existing evidence and the clinical experience of those working in primary care 
settings. Further, our analysis of the universal arm of the study did not identify any 
additional potential targets that had an odds ratio significantly better than universal 
screening alone. Increasing the number of targets may increase the coverage of the 
primary care population, but as the number of targets increase the approach 
becomes more complex to implement and starts to emulate universal screening.  
 
In terms of the relevance of the findings, we need to consider the results of this study 
alongside those of the larger trial exploring the effectiveness of brief interventions 
(Kaner et al., 2013b). The results of this study do not provide compelling evidence of 
any increased benefit of more intensive interventions compared with screening and 
feedback alone. In addition, there is some evidence of the potential benefit of 
opportunistic screening alone in reducing alcohol consumption (Jenkins et al., 2008; 
McCambridge and Day, 2007). It may be the case, particularly for those who 
consume alcohol at the lower end of the alcohol use spectrum, that screening with 
an appropriate tool and feedback of the screening results may have beneficial 
effects. In addition, this would be more acceptable to primary care practitioners, who 
have expressed concern over the additional burden of implementing alcohol 
screening and brief intervention (Aalto et al., 2003; Hutchings et al., 2006).  
 
In order to maximise the impact of alcohol screening and brief intervention in public 
health the results of this study point to universal screening being significantly more 
effective than targeted screening in primary care, akin to recommendations in dental 
care (Roked et al., 2014). This has important implications for policy and practice. The 
evidence presented here provides further scientific foundation for the National 
Institute for Health and Clinical Evidence guidance for alcohol screening (National 
Institute for Health and Clinical Excellence (NICE), 2009). This guidance 
recommends that where feasible and practical NHS professionals should routinely 
carry out alcohol screening as an integral part of clinical practice.  
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 Table 1: Mean (SD) clinician ratings for key conditions and contexts for targeted 
screening. 
 
  
n 
 
Mean rating (SD) 
 
 
 
Conditions 
Mental Health 
Gastrointestinal 
Hypertension 
Minor injuries 
 
Contexts 
New patients 
Chronic disease review 
Sexual health 
Smoking cessation 
 
 
 
 
86 
84 
82 
85 
 
 
85 
83 
81 
83 
 
 
 
1.60 (1.08) 
1.94 (1.08) 
2.17 (0.95) 
2.38 (1.01) 
 
 
1.69 (1.07) 
2.22 (1.01) 
2.35 (1.17) 
2.41 (1.06) 
 
 
 
Table 2: Demographics and reasons for attendance overall and by allocated group for 
those consenting to screen. 
 
  
Targeted 
(n = 1280) 
 
 
Universal 
(n = 1741) 
 
Overall 
(n=3021) 
 
 
Mean age in years (SD) 
 
Age group n (%) 
18 – 24 
25 – 34 
35 – 44 
45 – 54 
55 – 64 
65+ 
 
Males n (%) 
 
White n (%) 
 
Smoker n (%) 
 
Single n (%) 
 
Presentation n (%) 
 
Mental Health 
Gastrointestinal 
Hypertension 
Minor injuries 
New patients 
Other 
Not specified 
 
Screen positive n (%) 
 
Weekly episodic use n (%) 
 
 
48.9 (17.7) 
 
 
100 (7.8) 
193 (15.1) 
166 (13.0) 
206 (16.1) 
244 (19.2) 
368 (28.8) 
 
720 (56.3) 
 
1058 (82.7) 
 
342 (26.7) 
 
301 (23.6) 
 
 
 
167 (13.0) 
124 (9.7) 
623 (48.7) 
75 (5.9) 
273 (21.3) 
0 
18 (1.4) 
 
463 (36.2) 
 
382 (30.1) 
 
51.8 (18.4) 
 
 
141 (8.8) 
289 (16.8) 
287 (16.7) 
317 (18.3) 
311 (18.1) 
367 (21.3) 
 
722 (41.6) 
 
1401 (80.8) 
 
392 (22.6) 
 
478 (27.7) 
 
 
 
95 (5.5) 
73 (4.2) 
142 (8.2) 
23 (1.3) 
20 (1.1) 
1388 (79.7) 
0 
 
445 (25.6) 
 
352 (20.6) 
 
50.1 (18.0) 
 
 
251 (8.4) 
482 (16.1) 
453 (15.1) 
523 (17.4) 
555 (18.5) 
735 (24.5) 
 
1442 (47.8) 
 
2459 (81.6) 
 
734 (24.3) 
 
779 (26.0) 
 
 
 
262 (8.7) 
197 (6.5) 
765 (25.3) 
98 (3.2) 
293 (9.7) 
1388 (45.9) 
18 (0.7) 
 
908 (30.1) 
 
734 (24.7) 
 
 
 
Table 3: Odds ratio and 95% confidence intervals for screen positive in 
targeted group, overall and by presentation, compared to universal group. 
 
  
Screened  
n (%) 
 
 
Positive 
n (%) 
 
OR versus 
universal 
(95% CI) 
 
p-value 
 
Targeted Overall 
 
Targeted 
Presentation 
Mental Health 
Gastrointestinal 
Hypertension 
Minor Injuries 
New Patient 
 
Universal Overall 
 
Universal 
Presentation 
Mental Health 
Gastrointestinal 
Hypertension 
Minor injuries 
New patient 
No target 
 
 
1280 
 
 
169 (13.2) 
126 (9.8) 
633 (49.5) 
77 (6.0) 
275 (21.5) 
 
1741 
 
 
95 (5.4) 
73 (4.3) 
142 (8.2) 
23 (1.3) 
20 (1.1) 
1388 (79.7) 
 
463 (36.2) 
 
 
86 (50.9) 
44 (34.9) 
208 (32.8) 
30 (40.0) 
85 (30.9) 
 
445 (25.6) 
 
 
23 (24.2) 
20 (27.4) 
32 (22.5) 
4 (17.4) 
7 (35.0) 
359 (24.1) 
  
 
 
1.650 (1.411; 
1.931) 
 
 
3.092 (2.241; 
4.267) 
1.602 (1.092; 
2.350) 
1.460 (1.197; 
1.780) 
1.942 (1.208; 
3.120) 
1.317 (0.997; 
1.739) 
 
- 
 
 
0.927 (0.572; 
1.501) 
1.104 (0.652; 
1.868) 
0.835 (0.555; 
1.258) 
0.610 (0.206; 
1.802) 
1.577 (0.625; 
3.979) 
- 
 
<0.001 
 
 
<0.001 
0.02 
<0.001 
0.01 
0.05 
 
- 
 
 
0.76 
0.71 
0.39 
0.37 
0.33 
- 
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Table 4: Odds ratio and 95% confidence intervals for screen positive by age 
and gender in the universal screen group. 
 
  
Screened  
n (%) 
 
 
Positive 
n (%) 
 
OR  
(95% CI) 
 
p-value 
 
Age group 
18-24 
25-34 
35-44 
45-54 
55-64 
65 or more 
 
Sex 
Male 
 
 
 
 
151 (8.8) 
289 (16.8) 
287 (16.7) 
317 (18.4) 
311 (18.1) 
367 (21.3) 
 
 
722 (41.6) 
 
 
62 (41.1) 
99 (34.3) 
77 (26.8) 
86 (27.1) 
71 (22.8) 
47 (12.8) 
 
 
260 (36.0) 
  
 
 
 
2.183 (1.548; 
3.080)a 
1.656 (1.262; 
2.172) a 
1.075 (0.807; 
1.432) a 
1.097 (0.833; 
1.445) a 
0.829 (0.620; 
1.108) a 
0.357 (0.257; 
0.495) a 
 
 
2.539 (2.036; 
3.165) b 
 
 
<0.001 
<0.001 
0.622 
0.510 
0.206 
<0.001 
 
 
<0.001 
 
 
 
a Compared to all other age groups 
b Compared to females 
 
 
 
